UK News Archive

2018

November

Media Release / Nov 01, 2018

Novartis applies to the Court of Appeal following the recent judicial review on a Clinical Commissioning Group (CCG) policy related to the routine use of an unlicensed medicine on the NHS

Read More

October

Media Release / Oct 29, 2018

Two-year head-to-head data for Novartis brolucizumab reaffirm superiority versus aflibercept in reducing retinal fluid in patients with nAMD

Read More
Media Release / Oct 12, 2018

Novartis appeals the High Court judicial review judgment to defend the UK’s regulatory framework

Read More

September

Media Release / Sep 25, 2018

Novartis proposes to exit Grimsby UK site by end of 2020 as part of global manufacturing network transformation

Read More
Media Release / Sep 21, 2018

Patients asked to accept unlicensed treatment to save money

Read More
Media Release / Sep 18, 2018

Alzheimer’s survey reveals nearly half of UK adults believe a cure will be developed in their lifetime

Read More
Media Release / Sep 17, 2018

Novartis’ Tafinlar® (dabrafenib) + Mekinist® (trametinib): first BRAF-targeted therapy for adjuvant treatment of most aggressive form of skin cancer now available on NHS

Read More

July

Media Release / Jul 31, 2018

Novartis receives European licence for Aimovig®▼(erenumab), the first treatment designed specifically for the prevention of migraine

Read More
Story / Jul 09, 2018

The extraordinary need for an ordinary life

#NovartisIsWithYou

Read More
Story / Jul 05, 2018

NHS70: Reflections from our Managing Director and Country President, Haseeb Ahmad

Haseeb Ahmad
Novartis UK and Ireland Managing Director and Country President Haseeb Ahmad
Read More

Related Links